Silencing of NUP62 overcomes osimertinib resistance via ubiquitination of survivin in non-small cell lung cancer cells.

Park SS, Lee HW, Kwon MR, Ju EJ, Shin SH, Park J, Ko EJ, Son GW, Kim YJ, Moon GJ, Kim DH, Choi YJ, Rho JK, Park YY, Kim TW, Song SY, Jeong SY

Open source

DOI: 10.1038/s41416-026-03475-1
Published: 2026 Sep
Container: British journal of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41416-026-03475-1,
  title = {Silencing of NUP62 overcomes osimertinib resistance via ubiquitination of survivin in non-small cell lung cancer cells.},
  author = {Park SS and Lee HW and Kwon MR and Ju EJ and Shin SH and Park J and Ko EJ and Son GW and Kim YJ and Moon GJ and Kim DH and Choi YJ and Rho JK and Park YY and Kim TW and Song SY and Jeong SY},
  year = {2026},
  journal = {British journal of cancer},
  doi = {10.1038/s41416-026-03475-1},
  url = {https://doi.org/10.1038/s41416-026-03475-1}
}

RIS

TY  - JOUR
TI  - Silencing of NUP62 overcomes osimertinib resistance via ubiquitination of survivin in non-small cell lung cancer cells.
AU  - Park SS
AU  - Lee HW
AU  - Kwon MR
AU  - Ju EJ
AU  - Shin SH
AU  - Park J
AU  - Ko EJ
AU  - Son GW
AU  - Kim YJ
AU  - Moon GJ
AU  - Kim DH
AU  - Choi YJ
AU  - Rho JK
AU  - Park YY
AU  - Kim TW
AU  - Song SY
AU  - Jeong SY
PY  - 2026
JO  - British journal of cancer
DO  - 10.1038/s41416-026-03475-1
UR  - https://doi.org/10.1038/s41416-026-03475-1
ER  -

APA

SS, P., HW, L., MR, K., EJ, J., SH, S., J, P., EJ, K., GW, S., YJ, K., GJ, M., DH, K., YJ, C., JK, R., YY, P., TW, K., SY, S., & SY, J. (2026). Silencing of NUP62 overcomes osimertinib resistance via ubiquitination of survivin in non-small cell lung cancer cells.. British journal of cancer. https://doi.org/10.1038/s41416-026-03475-1

Source records

pubmed · retrieved 2026-09-25T10:43:37.754Z